Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amrize (AMRZ) Cash & Equivalents (2024 - 2025)

Amrize's Cash & Equivalents history spans 2 years, with the latest figure at $1.9 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 21.26% year-over-year to $1.9 billion; the TTM value through Dec 2025 reached $1.9 billion, up 21.26%, while the annual FY2025 figure was $1.9 billion, 21.26% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $1.9 billion at Amrize, up from $826.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.9 billion in Q4 2025 and bottomed at $601.0 million in Q2 2025.